Nadine van Montfoort

Leiden University Medical Center — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index2.1kcitations108works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(56), Viral gastroenteritis research and epidemiology(41), Cancer Research and Treatments(39), Immunotherapy and Immune Responses(22), CAR-T cell therapy research(16)

Publications108 total

Oncolytic virotherapy: Sparking durable anti-tumor immunity through microenvironment modulation
Seminars in Immunology·2025Open Access
Alphavirus replicons encoding IFN-γ enhance cancer virotherapy by overcoming macrophage-mediated suppression
iScience·2025Open Access
Inducing Cancer Cell Killing Using DNA Nanostructure-Mediated Superclustering of Death Receptors
Nano Letters·2025· 1 citedOpen Access
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
Nature Communications·2024Open Access
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
Nature Communications·2024· 21 citedOpen Access
Abstract 295: Fibroblast-specific endoglin deletion alters colonic immune infiltrate in premalignant colorectal lesions
Cancer Research·2024
Figure S2 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S6 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S6 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Supplementary Tables S1-S3 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S10 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S11 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S1 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S8 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S7 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S14 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S9 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S13 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S8 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S15 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
page 1 of 6Next →

Frequent Co-authors

Thorbald van Hall(18), Christianne Groeneveldt(16), Sjoerd H. van der Burg(15), Priscilla Kinderman(15), Rob C. Hoeben(13), Diana J.M. van den Wollenberg(11), Ferry Ossendorp(9), Camilla Labrie(9), Lisa Griffioen(9), Marjolein Sluijter(8), Andrea M. Woltman(8), Marij J.P. Welters(7), Marcel Camps(6), J. Sjef Verbeek(6), Sonja I. Buschow(6), Lukas J.A.C. Hawinkels(6), Cornelis J.M. Melief(5), Peter ten Dijke(5), John Hiscott(4), Selina Khan(4)